Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Actuate Therapeutics Inc., 2 years.
Actuate Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Actuate Therapeutics Inc. May 21, 202699.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | BlossomHill Therapeutics Inc. | Open-market purchase | +700 | $16.00 | $11,200 |
| Jan 23, 2025 | Equillium Inc. | Open-market sale | −10,000 | $0.65 | $6,500 |
| Dec 10, 2024 | Equillium Inc. | Grant or award | +15,000 | $0.54 | $8,100 |
| Nov 14, 2024 | Equillium Inc. | Open-market sale | −10,000 | $0.70 | $7,000 |
| Sep 26, 2024 | Equillium Inc. | Open-market sale | −10,000 | $0.81 | $8,100 |
| Jul 16, 2024 | Equillium Inc. | Open-market sale | −10,000 | $0.87 | $8,700 |
Questions about Jason A. Keyes
What boards is Jason A. Keyes on?
Jason A. Keyes sits on the board of Actuate Therapeutics Inc.
How long has Jason A. Keyes served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.